Ridgeline Therapeutics is Versant’s newest discovery engine aimed at translating new opportunities from academics into industry quality therapeutic candidates. Based in Basel, this central European location allows for privileged access to both strong academic research as well as large pharmaceutical partners. Alex Mayweg will provide...